Navigation Links
Wisconsin chooses likely vendors for BadgerNet 2

ation technology in an interview with WTN

University and state


The University of Wisconsin System is integral to the network plans, as its campuses will together hold many if not most of the users of the new voice and data services. Until this August, the university was laying plans for its own statewide network, which would have been built and administered in-house, ......

Full article >>>
'"/>

Source:wistechnology.com By Jason Stitt 10/25/04


Page: 1 2 3

Related biology technology :

1. To be a player in the "Knowledge Economy," Wisconsin needs more tech workers
2. Federal bioenergy lab will give Wisconsin a chance to shine
3. Breaking down Wisconsins angel capital numbers
4. Innovation featured in NE Wisconsin Roundtable
5. Visions: Broderick says Wisconsin should be in top third in venture capital
6. Wisconsin building toward the major leagues of venture capital
7. Wisconsin Supreme Court to hear Menasha software case
8. Wisconsin applicants urged to pursue DOE funding for cellulosic biomass
9. Legislature should look to Wisconsins natural energy advantages
10. Stem cells get most attention, but they are only part of Wisconsins bio-portfolio
11. BIO 2007: Wisconsin makes its presence felt

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Wisconsin chooses likely vendors for BadgerNet

(Date:11/6/2009)...Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biotech..."Company") today announced updated results from a ...nts with sarcomas metastatic to the lung in a post...ue Oncology Society Meeting held in Miami Beach, F...ntation, entitled "A Phase II Study of Intravenous...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 P...h is set to take place on February 22-24, 2010 in ...y conference we will highlight key issues in formi...are their experiences. , ...enda for Arrowhead’s 2010 Personalized Medi...
(Date:11/5/2009)...URG, Md., Nov. 5 GenVec,...al results for the third quarter ended September 3...n ($0.04 per share) for the three months ended Sep...lion ($0.08 per share) in the comparable quarter o...09, GenVec,s net loss was $14.1 million ($0.15 per...
(Date:11/5/2009)...Y, N.J., Nov. 5 DSM Pharmaceutical...acturing alliance with Galenix, Saint Jean D,Illac...al scale manufacturing partner for Galenix commerc...nix will collaborate on business development oppor...logies, based on the strength of Galenix in drug p...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...IA, Calif., April 28 MannKind,Corporation (Nasdaq...commercializing treatments for diabetes and cancer...an Stanley Healthcare Conference on Wednesday,Apri...Biscayne, Florida., Interested parties can access...n the Investor Relations section of the Company,s ...
...KNOLLS, N.J., April 28 Emisphere,Technologies, In...08 it,received a letter from the NASDAQ Stock Mark...st 10 consecutive trading days, the Company,s,mark...inimum $50,000,000,requirement for continued inclu...Q Marketplace Rule 4450(b)(1)(A). Furthermore, NAS...
...ND, Calif., April 28 Sangamo,BioSciences, Inc. (N...opment,of novel zinc finger DNA-binding proteins (...tion, announced today the nomination of Thomas G.,... Wiggans most recently served as Chief Executive O...ompany, from 1994, and as Chairman,of the Board fr...
Other Biology Technology:Emisphere Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements 2Emisphere Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements 3Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors 2Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors 3Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors 4
(Date:11/4/2009).... 26 BIO-key Internation...inger-based biometric identification software is s...the AABB TXPO conference being held at the New Orl...O-key will provide hands-on product demonstrations... in booth #424. Also, at 5 PM on Monday, October 2...
(Date:11/3/2009)...BER 4, 2009 -- The world,s greatest wines are the..., human input, and something called the "terroir" ..., and climate. , Experts will discuss terroir ... Wednesday, Nov. 4 in Pittsburgh. "Terroir: Wineg...o parts at the 2009 Annual Meetings of the America...
(Date:11/3/2009)... Obese women are as much as 28 percent less likel...cy, according to research that earned a Michigan S...e findings by Barbara Luke, a researcher in the MS...rics, Gynecology and Reproductive Biology, focused...roductive technology. , Luke,s findings, which a...
Breaking Biology News(10 mins):BIO-key(R) International Exhibiting at AABB TXPO 2Great wines come from great soils 2MSU researcher: Obesity significantly cuts odds of successful pregnancy 2Carefx Named an Innovative Information Access Company to Watch By Leading Market Research Firm 60229 1Carefx Named an Innovative Information Access Company to Watch By Leading Market Research Firm 60229 2Carefx Named an Innovative Information Access Company to Watch By Leading Market Research Firm 60229 3China Pharma Holdings Inc to Report Third Quarter 2009 Financial Results on November 12 2009 60226 1China Pharma Holdings Inc to Report Third Quarter 2009 Financial Results on November 12 2009 60226 2Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 1Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 2Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 3Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 4Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 5
...for controlling a first key step in the creation o... the journal Nature tomorrow (Thursday 27 October ... early processes that take place once a sperm ente...ndamental process in sexually reproducing animals....ternal (mother,s) genome explains why eggs fail to...
...toxicological study on water-soluble buckyballs, r...cal and Environmental Nanotechnology (CBEN) find t...ly less toxic to begin with. Moreover, the researc...ndered nontoxic with minor chemical modifications....studies of water-soluble carbon nanotubes. The stu...
...ty of California, San Diego that appears in the Au...hat females of the species Uca crenulata may check...ows before finally deciding on a mate. , “As far a...ing nearly as many candidates as the California fi... the study while a doctoral student and a lecturer...
Other Biology News:Scientists unpick genetics of first 15 minutes of life 2Modifications render carbon nanotubes nontoxic 2Modifications render carbon nanotubes nontoxic 3Biologist Discovers What May Be World’s ‘Pickiest?Mates 2Biologist Discovers What May Be World’s ‘Pickiest?Mates 3
GIBCO Streptomycin Sulfate from Invitrogen
GIBCO Dulbeccos Modified Eagle Medium (D-MEM) (1X); powder (low glucose) from Invitrogen
Goat Anti-Adducin beta (C-16) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Rat TNF-alpha ELISA Kit, OptEIA from BD Biosciences Pharmingen
Biology Products: